Director, Office of Program Evaluation, Analysis and Reporting, Division of Clinical Innovation
National Center for Advancing Translational Sciences, National Institutes of Health
Atlanta, Georgia, United States
Robin M. Wagner, PhD, MS, is the Director of the Office of Program Evaluation, Analysis, and Reporting in the Division of Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), within the National Institutes of Health (NIH). Dr. Wagner has worked in the environmental health and injury fields for 30+ years in government, university and non-profit settings. For 20 years, she has built teams that applied advanced statistical methods to administrative data to support policy and decision making. Prior to joining NCATS, Dr. Wagner served as a Senior Advisor in NIH’s National Heart, Lung, and Blood Institute, focusing on data science and policy initiatives.
From 2014 ̶̶ 2021, Wagner served as Chief Science Officer for the Centers for Disease Control and Prevention (CDC) Deputy Director for Public Health Science and Surveillance. She also directed the Division of Statistical Analysis and Reporting in NIH’s Office of Extramural Research (OER) for six years, leading an interdisciplinary team of data scientists which analyzed NIH’s research investments and workforce, providing decision support to NIH executive leadership. Prior to that, she spent 12 years at CDC in research, policy and leadership roles. As Associate Director for Research Planning and Evaluation in the Office of Public Health Research, she oversaw the development of CDC’s first agency-wide research agenda and research portfolio assessment program.
Wagner was a board member of the Massachusetts Institute of Technology (MIT) Corporation and MIT Alumni Association and spent 17 years as a member of the MIT Visiting Committee on Sponsored Research. Since 2012, she has co-chaired the American Evaluation Association’s Research, Technology and Development Evaluation Topic Interest Group. She has a Ph.D. in Epidemiology from the Johns Hopkins Bloomberg School of Public Health, a M.S. in Technology and Policy from MIT, and a Sc.B. in Neuroscience and Behavior from Brown University..
Disclosure information not submitted.
Friday, October 13, 2023
1:00 PM – 2:00 PM ET